Scotia Capital’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-40,634
| Closed | -$135K | – | 675 |
|
|
2016
Q1 | $135K | Sell |
40,634
-90,682
| -69% | -$301K | ﹤0.01% | 541 |
|
|
2015
Q4 | $650K | Hold |
131,316
| – | – | 0.01% | 385 |
|
|
2015
Q3 | $662K | Buy |
131,316
+5,331
| +4% | +$26.9K | 0.02% | 375 |
|
|
2015
Q2 | $797K | Sell |
125,985
-6,160
| -5% | -$39K | 0.02% | 355 |
|
|
2015
Q1 | $930K | Buy |
132,145
+2,927
| +2% | +$20.6K | 0.02% | 319 |
|
|
2014
Q4 | $995K | Sell |
129,218
-2,508
| -2% | -$19.3K | 0.03% | 298 |
|
|
2014
Q3 | $983K | Buy |
131,726
+9,497
| +8% | +$70.9K | 0.02% | 306 |
|
|
2014
Q2 | $1.18M | Buy |
122,229
+5,389
| +5% | +$52.2K | 0.03% | 280 |
|
|
2014
Q1 | $970K | Buy |
116,840
+15,991
| +16% | +$133K | 0.02% | 304 |
|
|
2013
Q4 | $851K | Buy |
100,849
+9,720
| +11% | +$82K | 0.02% | 293 |
|
|
2013
Q3 | $727K | Buy |
91,129
+23,927
| +36% | +$191K | 0.02% | 293 |
|
|
2013
Q2 | $518K | Buy |
+67,202
| New | +$518K | 0.02% | 288 |
|